Clinical Trial Update: Phase I Dose Escalation Study to Investigate the Safety of ISTH0036 in Subjects With Glaucoma Undergoing Trabeculectomy [Phase 1]

View source ↗

Summary

A completed Phase I dose-escalation trial evaluating the safety of ISTH0036 in subjects with primary open-angle glaucoma undergoing trabeculectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Open-angle Glaucoma

Drugs mentioned

• ISTH0036

Snippet

Sponsor: Isarna Therapeutics GmbH | Conditions: Primary Open Angle Glaucoma | Phase 1 | Status: COMPLETED